Chapter 035

Adrenal Corticosteroids

Clarence L. Trummel

CITED REFERENCES

  1. Adachi JD, Bensen WG, Hodsman AB: Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 22:375-384, 1993. PUBMED Abstract
  2. Barnes PJ: Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875, 1995. PUBMED Abstract
  3. Blonde LRR, Tullman MJ, Redding SW: Endocrinologic disease. In Tullman MJ, Redding SW, editors: Systemic disease in dental treatment, New York, 1982, Appleton-Century-Crofts.
  4. Goldstein RA, Paul WE, Metcalfe DD, et al: Asthma. Ann Intern Med 121:698-708, 1994. PUBMED Abstract
  5. Mico-Llorens JM, Satorres-Nieto M, Gargallo-Albiol J: Efficacy of methylprednisolone in controlling complications after impacted lower third molar surgical extraction. Eur J Clin Pharmacol 62:693-698, 2006. PUBMED Abstract
  6. Miller CS, Little JW, Falace DA: Supplemental corticosteroids for dental patients with adrenal insufficiency: reconsideration of the problem. J Am Dent Assoc 132:1570-1579, 2001. PUBMED Abstract
  7. Norman AW, Mizwicki MT, Norman DP: Steroid hormone rapid actions, membrane receptors, and a conformational ensemble model. Nat Rev Drug Discov 3:27-41, 2004. PUBMED Abstract
  8. Pilkis SJ, Granner DK: Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54:885-902, 1992. PUBMED Abstract
  9. Piper JM, Ray WA, Daugherty JR, et al: Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 114:735-740, 1991. PUBMED Abstract
  10. Ramos-Remus C, Sibley J, Russell AS: Steroids in rheumatoid arthritis: the honeymoon revisited. J Rheumatol 19:667-670, 1992. PUBMED Abstract
  11. Saag KG, Emkey R, Schnitzer TJ, et al: Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292-299, 1998. PUBMED Abstract
  12. Sciubba JJ: Oral mucosal diseases in the office setting, part I: aphthous stomatitis and herpes simplex infections. Gen Dent 55:347-354, 2007. PUBMED Abstract
  13. Sciubba JJ: Oral mucosal diseases in the office setting, part II: lichen planus, pemphigus vulgaris and mucosal pemphigoid. Gen Dent 55:464-476, 2007. PUBMED Abstract
  14. Webster JC, Cidlowski JA: Mechanism of glucocorticoid-receptor mediated repression of gene expression. Trends Endocrinol Metab 10:396-402, 1999. PUBMED Abstract
  15. Williams GH, Dluhy RG: Disorders of the adrenal cortex. In Fauci AS, Braunwald E, Isselbacher KJ, et al, editors: Harrison’s principles of internal medicine, ed 15, New York, 2008, McGraw-Hill, pp 2227-2269.

GENERAL REFERENCES

  1. Schimmer BP, Parker KL: Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In Brunton LL, Lazo JS, Parker KL, editors: Goodman & Gilman’s the pharmacological basis of therapeutics, ed 11, New York, 2006, McGraw-Hill.